Zagadat Capital GH. Ltd has acquired a 17.31 per cent stake in Intravenous Infusions PLC, a key player in Ghana's pharmaceutical manufacturing sector. The investment firm, led by Nigerian musician and entrepreneur Oluwatosin “Mr Eazi” Ajibade as Chief Investment Officer, bought over 47.5 million shares. This significant acquisition was completed through open-market purchases on the Ghana Alternative Exchange (GAX).
This move signals a substantial boost for investor confidence in Ghana's ability to produce essential medical supplies. Intravenous Infusions PLC is a wholly Ghanaian company that manufactures vital intravenous fluids, saline solutions, and other pharmaceutical products. The company's recent 2025 annual report highlighted its resilience and importance in the local healthcare system.
The acquisition fits into a broader narrative of increasing foreign and domestic investment in Ghana's industrial base. Recent economic data has shown a focus on strengthening local manufacturing capabilities. Companies like Intravenous Infusions PLC are seen as crucial for reducing import reliance for essential goods. The Ghana Stock Exchange has been working to attract both local and international capital. This investment by Zagadat Capital follows other efforts to bolster the financial markets.
Zagadat Capital stated that the shares were bought as part of a long-term strategy to expand Ghana's healthcare supply chain. The firm believes in the viability of local medicine production. They view Intravenous Infusions PLC as vital to the West African healthcare system. The investment is not intended to lead to a takeover or destabilise the company's management. Zagadat Capital aims to build a supportive partnership for growth and value creation. The disclosure followed strict rules under the Securities Industry Act, 2016 (Act 929).
This investment, amounting to a substantial sum of money, is expected to strengthen Intravenous Infusions PLC's operational capacity. It may lead to increased production and potentially new product lines. Investors will watch for any strategic shifts or expansion plans from the company. The move also underscores Mr Eazi's growing influence in the corporate and investment landscape. Zagadat Capital's clear statement of intent to collaborate is a positive sign for existing shareholders. Further details on the financial value of the transaction are expected to be clarified.